湯寧信
醫學院(FMD)
ORCID: 0000-0001-6717-5444
ResearcherID: AAD-9404-2019; P-5365-2015
成果: 782 件 | 合作者:4052
WOS核心合集引用:17088 | H Index:62 | WOS收錄:611
CNKI收錄:15 | SCOPUS收錄:501
論文: 782
1.An up-to-date review of emerging biologic therapies for hypercholesterolemia
Tomlinson, B
EXPERT OPINION ON BIOLOGICAL THERAPY[1471-2598], Published 2025, Volume 25, Issue 1, Pages 69-78
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 3.6
2.Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia
Tomlinson, B, Chan, More...
EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2025, Volume 26, Issue 3, Pages 279-289
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 2.5
Wang, YF, Wang, XY, More...
ADVANCED SCIENCE[2198-3844], Published 2025,
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 14.3
4.Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors
Tomlinson, Brian, Wu More...
Journal of Lipid and Atherosclerosis[2287-2892], Published 2024, Volume 13, Issue 1, Pages 2-20
收錄情况: SCOPUS
Jin, Q, Lau, ESH, Lu More...
DIABETOLOGIA[0012-186X], Published 2024, Volume 67, Issue 5, Pages 837-849
收錄情况: WOS SCOPUS
WOS核心合集引用: 5 2023影響因子: 8.4
6.Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Suzuki, K, Hatzikoto More...
NATURE[0028-0836], Published 2024, Volume 627, Issue 8003, Pages 347-357
收錄情况: WOS SCOPUS
WOS核心合集引用: 79 2023影響因子: 50.5
Tomlinson, B, Chan, More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2024, Volume 20, Issue 4, Pages 175-179
收錄情况: WOS SCOPUS
WOS核心合集引用: 1 2023影響因子: 3.9
Tomlinson, B, Chow, More...
HONG KONG MEDICAL JOURNAL[1024-2708], Published 2024, Volume 30, Issue 2, Pages 184-185
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 3.1
Zeng, WW, Chu, TTW, More...
HELIYON[2405-8440], Published 2024, Volume 10, Issue 14,
收錄情况: WOS SCOPUS
WOS核心合集引用: 1 2023影響因子: 3.4
本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器
Copyright © 2018 澳門科技大學學者庫